OIG Report on Supplement Claims Finds Disease Claims, Substantiation Issues
This article was originally published in The Tan Sheet
Executive Summary
The HHS Office of the Inspector General finds a number of issues with supplement structure/function claims, and makes several recommendations to FDA to reduce illegal claims and weak substantiation.
You may also be interested in...
Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
Tainted Supplement Recalls Prompt Call For Tighter Regulations – Letter
A research letter says that tainted supplements accounted for more than half of class I recalls from 2004-2012, and the researchers argue for stricter regulation. Industry points to a steep drop-off after 2010, and call for stronger enforcement of existing regulations.